DR Reddy S Laboratories Limited — Fexofenadine Exporter Profile
Indian Pharmaceutical Exporter · #10 for Fexofenadine · $15.3M export value · DGFT Verified
DR Reddy S Laboratories Limited is the #10 Indian exporter of Fexofenadine with $15.3M in export value and 23 verified shipments. DR Reddy S Laboratories Limited holds a 1.0% market share in Fexofenadine exports across 3 countries. The company exports 50 pharmaceutical products worth $310.6M across 19 therapeutic categories.
DR Reddy S Laboratories Limited — Fexofenadine Export Profile: Buyers & Destinations
Where Does DR Reddy S Laboratories Limited Export Fexofenadine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $3.0M | 67 | 71.4% |
| UNITED STATES | $850.0K | 17 | 20.3% |
| UNITED STATES OF AMERICA | $200.0K | 4 | 4.8% |
| AUSTRALIA | $128.9K | 8 | 3.1% |
| NEW ZEALAND | $17.1K | 2 | 0.4% |
DR Reddy S Laboratories Limited exports Fexofenadine to 5 countries. The largest destination is UNITED KINGDOM accounting for 71.4% of DR Reddy S Laboratories Limited's Fexofenadine shipments, followed by UNITED STATES (20.3%) and UNITED STATES OF AMERICA (4.8%). These destinations reflect DR Reddy S Laboratories Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Fexofenadine from DR Reddy S Laboratories Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MOVIANTO UK LIMITED | UNITED KINGDOM | $2.2M | 51 |
| MOVIANTO UK LTD | UNITED KINGDOM | $757.2K | 16 |
| DR REDDYS LABORATORIES INC | UNITED STATES | $350.0K | 7 |
| XX REXXYS XXBORXXORIXX INXX | UNITED STATES OF AMERICA | $250.0K | 5 |
| REED-LANE INC | UNITED STATES | $200.0K | 4 |
| DR REDDY S LABORATORIES AUSTRALIA PTY LIMITED | AUSTRALIA | $103.3K | 5 |
| REED LANE INC 359 NEW WARK | UNITED STATES | $100.0K | 2 |
| REED LANE INC | UNITED STATES | $50.0K | 1 |
| REED - LANE INC | UNITED STATES | $50.0K | 1 |
| XXED XXNE XXC | UNITED STATES OF AMERICA | $50.0K | 1 |
DR Reddy S Laboratories Limited supplies Fexofenadine to 13 buyers globally. The largest buyer is MOVIANTO UK LIMITED (UNITED KINGDOM), followed by MOVIANTO UK LTD (UNITED KINGDOM) and DR REDDYS LABORATORIES INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Fexofenadine Export Value and How Much Does DR Reddy S Laboratories Limited Contribute?
India exported $81.9M worth of Fexofenadine through 4,236 shipments from 224 suppliers to 97 countries, serving 599 buyers globally. DR Reddy S Laboratories Limited contributes $15.3M to this total, accounting for 1.0% of India's Fexofenadine exports. DR Reddy S Laboratories Limited ships Fexofenadine to 5 countries through 13 buyers.
What Is the Average Shipment Value for DR Reddy S Laboratories Limited's Fexofenadine Exports?
DR Reddy S Laboratories Limited's average Fexofenadine shipment value is $667.0K per consignment, based on 23 shipments totaling $15.3M. The largest destination is UNITED KINGDOM (71.4% of DR Reddy S Laboratories Limited's Fexofenadine exports).
How Does DR Reddy S Laboratories Limited Compare to Other Indian Fexofenadine Exporters?
DR Reddy S Laboratories Limited ranks #10 among 224 Indian Fexofenadine exporters with a 1.0% market share. The top 3 exporters are IND SWIFT LIMITED ($14.6M), CIPLA LIMITED ($13.6M), DR.REDDY'S LABORATORIES LTD ($12.4M). DR Reddy S Laboratories Limited processed 23 shipments to 3 destination countries.
What Fexofenadine Formulations Does DR Reddy S Laboratories Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FEXOFENADINE HYDROCHLORIDE TABLETS | $350.0K | 7 |
| FEXOFENADINE HYDROCHLORIDE TABLETS USP | $350.0K | 7 |
| FEXOFENADINE HYDROCHLORIDE 120MG FILM-CO | $185.7K | 5 |
| FEXOFENADINE HYDROCHLORIDE 180MG FILM-CO | $138.7K | 4 |
| FEXOFENADINE HYDROCHLORIDE 180MG FILM-COATED TABLETS 30S 38657 X 30S PACK | $115.7K | 3 |
| FEXOFENADINE HCL 60MG AND PSEUDOEPHEDRINE HCL 120MG ER TABLETS USP12HOUR ALLERGY CONGESTION 35S 29970X35S=1048950NOS | $100.0K | 2 |
| FEXOFENADINE HCL 60MG AND PSEUDOEPHEDRINE HCL 120MG ER TABLETS USP12HOUR ALLERGY CONGESTION 35S 33780X35S=1182300NOS | $100.0K | 2 |
| FEXOFENADINE HYDROCHLORIDE 180MG FILM-COATED TABLETS 30S 57514 X 30S | $50.0K | 1 |
| FEXOFENADINE HYDROCHLORIDE 180MG FILM COATED TABLETS 30 S 76954 X 30 S PACKS=2308620 NOS | $50.0K | 1 |
| FEXOFENADINE HYDROCHLORIDE 180MG FILM-COATED TABLETS 30 S 38801 X 30 S PACKS=1164030 NOS | $50.0K | 1 |
DR Reddy S Laboratories Limited exports 75 distinct Fexofenadine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FEXOFENADINE HYDROCHLORIDE TABLETS with 7 shipments worth $350.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Fexofenadine to Key Markets
What DR Reddy S Laboratories Limited must comply with to export Fexofenadine to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does DR Reddy S Laboratories Limited Compare to Nearest Fexofenadine Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | MICRO LABS LIMITED | $2.4M | 135 | 14 | $17.5K |
| 11 | IND-SWIFT LIMITED | $2.3M | 63 | 11 | $36.8K |
| 12 | DR.REDDY'S LABORATORIES LIMITED ★ | $1.7M | 48 | 2 | $36.3K |
| 14 | ZENTIVA PRIVATE LIMITED | $1.7M | 48 | 1 | $36.0K |
| 15 | CADILA PHARMACEUTICALS LIMITED | $1.6M | 74 | 9 | $21.5K |
DR Reddy S Laboratories Limited ranks #10 among 224 Indian Fexofenadine exporters. Average shipment value of $36.3K compared to the market average of $365.5K. The closest competitors by value are MICRO LABS LIMITED and IND-SWIFT LIMITED.
Which Indian Ports Ship Fexofenadine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 569 | 13.4% |
| JNPT/ NHAVA SHEVA SEA | 385 | 9.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 362 | 8.5% |
| NHAVA SHEVA SEA (INNSA1) | 350 | 8.3% |
| HYDERABAD ICD | 229 | 5.4% |
| CHAWAPAYAL ICD | 186 | 4.4% |
| JNPT | 161 | 3.8% |
| CHAWAPAYAL ICD (INCPR6) | 142 | 3.4% |
What Other Antihistamines & Allergy Products Does DR Reddy S Laboratories Limited Export?
DR Reddy S Laboratories Limited also exports these antihistamines & allergy products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on DR Reddy S Laboratories Limited's Fexofenadine Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Dr. Reddy's. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. Dr. Reddy's, with its established presence and compliance with stringent regulatory standards, is well-positioned to capitalize on this shift.
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Dr. Reddy's commitment to quality and regulatory adherence ensures its continued access to the EU market, despite the evolving regulatory landscape.
DR Reddy S Laboratories Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for Dr. Reddy's. The company has consistently adhered to FDA, WHO, and EU Good Manufacturing Practices (GMP), ensuring the quality and safety of its products. This commitment is crucial in sustaining trust and credibility in global markets.
However, regulatory challenges persist. In April 2025, Dr. Reddy's received a show cause notice from the Indian Income Tax Department concerning a proposed demand of over ₹2,395 crore related to the merger of Dr. Reddy's Holding Ltd with itself. The company has stated its belief that there is no tax liability arising from the merger and is addressing the matter through appropriate channels. (business-standard.com)
About DR Reddy S Laboratories Limited
DR Reddy S Laboratories Limited exports 50 products worth $310.6M. Beyond Fexofenadine, top products include Metoprolol, Omeprazole, Clopidogrel, Esomeprazole, Magnesium. View the complete DR Reddy S Laboratories Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fexofenadine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fexofenadine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: DR Reddy S Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 98 individual customs records matching DR Reddy S Laboratories Limited exporting Fexofenadine, covering 75 formulations to 5 countries via 13 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 97+ countries, 599+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fexofenadine Export Data from DR Reddy S Laboratories Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for DR Reddy S Laboratories Limited's Fexofenadine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
DR Reddy S Laboratories Limited
Full Company Profile →
50 products · $310.6M total trade · 19 categories
Fexofenadine Stats
Company Overview
Top Products by DR Reddy S Laboratories Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for DR Reddy S Laboratories Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fexofenadine. For current shipment-level data, contact TransData Nexus.